COMMUNIQUÉS West-GlobeNewswire

-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
06/09/2024 -
Psyence Biomed Announces the Signing of a Conditional Binding Term Sheet for the Acquisition of Psilocybin-Based Drug Developer Clairvoyant
06/09/2024 -
Y-mAbs Presents Neuroblastoma Research on Naxitamab and SADA PRIT Technology Platform at AACR Special Conference on Advances in Pediatric Cancer Research
06/09/2024 -
Cartesian Therapeutics Announces New Employment Inducement Grant
06/09/2024 -
Nurix Therapeutics To Participate in Upcoming ADC & Radiopharmaceuticals Pharma & Biotech Partnering Summit
06/09/2024 -
Tonix Pharmaceuticals Launches National Awareness Campaign on the Impact of Gastroparesis or Stomach Paralysis on the Absorption of Oral Migraine Medications at PAINWeek
06/09/2024 -
Milestone Partner Ji Xing Pharmaceuticals Ltd Announces Positive Topline Results from the Phase 3 Study of Etripamil in PSVT in China
06/09/2024 -
Entrada Therapeutics Announces Recipients of Second Annual Diversity, Representation, Equity and Advocacy MatterS (DREAMS) Grant Program
06/09/2024 -
Krystal Biotech to Present at H.C. Wainwright 26th Annual Global Investment Conference
06/09/2024 -
Axogen Completes Submission of Biologics License Application to U.S. Food and Drug Administration for Avance Nerve Graft®
06/09/2024 -
Immatics Announces Upcoming Oral Presentation at the Society for Melanoma Research Congress 2024
06/09/2024 -
BioConnection appoints Richard Sewalt as New Chief Commercial Officer
06/09/2024 -
Oragenics, Inc. Announces Closing of Public Offering
05/09/2024 -
Nyxoah to Participate in Upcoming Investor Conferences
05/09/2024 -
Nyxoah Participera à de Prochaines Conférences d'Investisseurs
05/09/2024 -
Aptose Announces Results from Special Meeting of Shareholders
05/09/2024 -
Lifecore Biomedical to Participate in 17th Annual Barrington Research Virtual Fall Investment Conference
05/09/2024 -
Celularity to Present at H.C. Wainwright’s 26th Annual Global Investment Conference
05/09/2024 -
Connect Biopharma Reports First Half 2024 Financial Results and Provides Business Update
05/09/2024
Pages